Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
It's the same drug formulated differently to make it easier to give accurate age/size-specific doses and can be mixed with food. But I agree, take up will take time. For me Chronocort very much meets unmet needs as it is able to mimic circadian variations in the natural hormone and this has a much stronger case for rapid uptake given the potential health benefits for CAH patients.
QF
And another blue day with reasonable volume. Hoping for a solid, sustained £1 this year ...
And I see LogP is now up a little too ...
I suppose more of a niche than a club ...
Even more joy today as, probably like many others, my portfolio is entirely blue (except logP which is unchanged attow).
SLE is an interesting share which has caused me sleepless nights at times having originally "invested" for the Polish potential.
Since the pandemic began a lot of speculative AIM money has gone into health and green stocks. In this context it is perhaps unsurprising SLE hasn't had more interest despite all the positives listed by Alaric and others previously. SLE is also not perceived as a potential "multibagger" which is what many punters on AIM are looking (hoping) for. And I guess at the other end of the risk spectrum - i.e., those more conservative investors looking at dividends - SLE is perceived as too high risk because of the Nigerian aspect. So here we are in a little club.
QF
Well plausible doesn't mean I'm happy about it. I suspect OF has the resources to have purchased at least some of the 98 million or is it all or nothing?
Knee jerk reaction was negative. However, on reflection, can only assume OF has been trying to raise the money against other assets the valuation of which is uncertain in these times. Plausible? Yes.
SaleSale
I don't get it. We are now around the minimum of the last 5 weeks.
>>AZN.NAS AstraZeneca : Jefferies raises price target to $56.50 from $52.50..
Equivalent to about £85 per share (x2 and convert) if I understand correctly
Seaking1 yes no offence taken??
Actually, I haven't been paying close attention to this one. I was a long-term holder but got out many months back. Looking to buy back in at some point. Having trouble separating the pharma-covid linked rise from real value so still waiting it out ...
>>Quel, do pay attention it’s paid for by the government hence no loss to AstraZeneca.
So all those people working on the vaccine while their time is paid for are not working on for profit things? Are they being compensated for that ... just trying to work out why the price has dropped.
>>70% is great news but not as good as some of the others, hence the SP drop today.
I thought it was not for profit so the fact that they appear to have succeeded in developing a vaccine (whilst undoubtedly a good thing!) will result in a dent in profits???
Malcy says:
Providence Resources/Lansdowne
Much has been going on at Providence Resources since the new CEO, Alan Linn was appointed in January, and I was fortunate to catch up with him earlier in the week. The company is now totally focused upon economically developing the Barryroe Oil and Gas Field in the North Celtic Sea, offshore County Cork. In addition it is assessing the potential for developing Carbon Capture and Storage (CCS) in the North Celtic Sea linked with the Barryroe field, to produce an integrated, sustainable, hydrocarbon development.
PVR has clearly changed, not only is the focus changed but the model is different as well. Working with SpotOn Energy who, along with a very experienced group of around 6 service companies fully fund development of the field in return for an equity stake, they use their Norwegian base to source export credit and fiscal advantages. These oil service companies can get life of field contracts and are paid from field production and then a royalty stream based on a risk adjusted share of net cash flow defined by SpotOn.
Thus the funding of such a development is changed completely, indeed top-up funding might be provided by bonds issued by the companies who will stand behind them and underwrite them thus increasing the efficiency. Moreover this is not necessarily restricted to Barryroe, if it proves to be successful this model might be rolled out elsewhere.
So, PVR is now all about Barryroe and the North Celtic Sea which will now be linked to develop the CCS and with a gas pipeline running through the licence gives scope for significant CO2 storage which could feed the 2X500 MW power stations onshore Cork. Finally on this it is easy to see how the whole process adds significantly to the companies ESG credentials.
I have much more to talk about from my meeting notes but I wanted to make a few points about Providence ahead of their presentation at Proactive this evening. Alan Linn has got many plans and he is highly realistic about fossil fuels, or as he calls them ‘naturally occurring hydrocarbons’ and Barryroe’s 43° API crude with no sulphur that gets a premium to Brent does that.
So the plan is, phased Development of the Barryroe Gas and Oil resources with partners capable of funding the development work programme, as per the above. They will establish early production and cashflow and
minimise overall development risk and provide a phased Oil and Gas Development.
It is high on the list to achieve a sustainable, carbon neutral development with significant upside under existing medium term drilling plans, within the Barryroe field. In addition a number of these exciting developments PVR has the ability to make the field a hub for such as Helvick and Dunmore.
Providence is a changed animal, all the rest of the portfolio is being submitted as relinquishments and the new PVR is, in my opinion very exciting. I have only had one interview with ‘new’ CEO Alan Linn and he is very impressive, that my
couldn't've - even worser ;-) ho ho
My view is that with traders gone and the big seller gone plus the low free float the price could easily trickle gradually upwards on persistent small buys even with low volumes.
DM Yes my thoughts too. Not even played, just nerves ...
I've been looking here:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=report.page
but not sure if this is where the first notification is made?
To be fair HL won't quote to buy either unless v small no. of shares ...
A number of small sells appear to be driving the sp down, hardly likely to be those in the know. Far outweighed by earlier buys.
A don't know what is on L2, anyone?
HL won't give a sell price right now.